Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo
Finn, Aloke V., MD, Oh, Jae S., BS, Hendricks, Michael, BS, Daher, Maureen, RN, Cagliero, Enrico, MD, Byrne, Raphael M, Nadelson, Jeffrey, BS, Crimins, Johanna, BS, Kastrati, Adnan, MD, Schömig, Albert, MD, Bruskina, Olga, BS, Palacios, Igor, MD, John, Michael C., MPH, Gold, Herman K., MD
Published in The American heart journal (01.02.2009)
Published in The American heart journal (01.02.2009)
Get full text
Journal Article